Literature DB >> 2316706

Model of placental glucose consumption and glucose transfer.

W W Hay1, R A Molina, J E DiGiacomo, G Meschia.   

Abstract

Net ovine uteroplacental glucose consumption (Ro,up) and transfer rates to the fetus (Rf,up) were measured at different concentrations of maternal (GA) and fetal (Ga) arterial plasma glucose that were set and maintained independently by a glucose clamp procedure. Five GA/Ga combinations were studied: 70/15, 70/20, 70/30, 50/14, and 50/24 mg/dl. Rf,up was inversely related to Ga both at GA = 70 and GA = 50. Linear regression analysis of Rf,up vs. Ga for the GA = 70 and GA = 50 groups of observations revealed similar slopes (-0.286 +/- 0.012 vs. -0.217 +/- 0.028 dl.min-1.kg fetus-1) but a significantly higher intercept for the GA = 70 group (10.3 +/- 0.12 vs. 5.5 +/- 0.47 mg.min-1.kg fetus-1). In contrast, Ro,up increased significantly in response to an increase of Ga and had no significant dependence on GA. These results indicate that uteroplacental glucose metabolism occurs primarily in tissues that have direct access to glucose molecules carried by the umbilical circulation and that the glucose transport capacity of the placental barrier is greater on its fetal than its maternal surface. Uteroplacental glucose metabolic rate and its dependence on fetal glucose concentration are major factors that determine the magnitude and variability of the glucose concentration gradient (and thus the rate of net glucose transfer) between maternal and fetal plasma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2316706     DOI: 10.1152/ajpregu.1990.258.3.R569

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  22 in total

1.  Coordinated changes in hepatic amino acid metabolism and endocrine signals support hepatic glucose production during fetal hypoglycemia.

Authors:  Satya S Houin; Paul J Rozance; Laura D Brown; William W Hay; Randall B Wilkening; Stephanie R Thorn
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-12-16       Impact factor: 4.310

2.  A theoretical model of glucose transport suggests symmetric GLUT1 characteristics at placental membranes.

Authors:  Efrath Barta; Arieh Drugan
Journal:  J Membr Biol       Date:  2014-06-04       Impact factor: 1.843

Review 3.  Placental Origins of Chronic Disease.

Authors:  Graham J Burton; Abigail L Fowden; Kent L Thornburg
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

4.  Role of placental insufficiency and intrauterine growth restriction on the activation of fetal hepatic glucose production.

Authors:  Stephanie R Wesolowski; William W Hay
Journal:  Mol Cell Endocrinol       Date:  2015-12-23       Impact factor: 4.102

Review 5.  The intrauterine growth restriction phenotype: fetal adaptations and potential implications for later life insulin resistance and diabetes.

Authors:  Stephanie R Thorn; Paul J Rozance; Laura D Brown; William W Hay
Journal:  Semin Reprod Med       Date:  2011-06-27       Impact factor: 1.303

6.  Chronic anemic hypoxemia increases plasma glucagon and hepatic PCK1 mRNA in late-gestation fetal sheep.

Authors:  Christine Culpepper; Stephanie R Wesolowski; Joshua Benjamin; Jennifer L Bruce; Laura D Brown; Sonnet S Jonker; Randall B Wilkening; William W Hay; Paul J Rozance
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-05-11       Impact factor: 3.619

7.  Ovine feto-placental metabolism.

Authors:  J W Ward; F B P Wooding; A L Fowden
Journal:  J Physiol       Date:  2003-10-31       Impact factor: 5.182

8.  Glucose replacement to euglycemia causes hypoxia, acidosis, and decreased insulin secretion in fetal sheep with intrauterine growth restriction.

Authors:  Paul J Rozance; Sean W Limesand; James S Barry; Laura D Brown; William W Hay
Journal:  Pediatr Res       Date:  2009-01       Impact factor: 3.756

Review 9.  Placental-fetal glucose exchange and fetal glucose metabolism.

Authors:  William W Hay
Journal:  Trans Am Clin Climatol Assoc       Date:  2006

Review 10.  The pregnant sheep as a model for human pregnancy.

Authors:  J S Barry; R V Anthony
Journal:  Theriogenology       Date:  2007-11-05       Impact factor: 2.740

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.